Patent · US Active

Oncolytic virus expressing a car T cell target and uses thereof

US12364724B2 · kind B2 · utility

0Cited by

3References

11Claims

0Family size

Assignee

City of Hope · US

Inventors

Yuman Fong · Duarte, US
Saul J. Priceman · McNeil, US
Stephen J. Forman · Duarte, US
Nanhai Chen · San Diego, US
Anthony K. Park · Duarte, US

Key dates

Filing date	Aug 10, 2018
Grant date	Jul 22, 2025
Priority date	—
Expiry date	Nov 28, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2770/32032
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An oncolytic poxvirus encoding a truncated human CD19 is used in conjunction with a chimeric antigen receptor to treat solid tumors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.